US-Listed Pharmaceutical Preparations — Operating Income Percentiles, FY 2023

Population: 574 US-listed companies (SIC 2834), fiscal year 2023; fiscal year ends 2023-06-30 to 2024-05-31.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile	$-193.6M
25th percentile	$-95.9M
Median	$-34.7M
75th percentile	$-8.2M
90th percentile	$-364.6k
Mean	$-15.2M
Minimum	$-4.0B
Maximum	$12.8B

Methodology & sources
Operating Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2023 = fiscal years ending 2023-06-01 to 2024-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest Operating Income percentiles (live) · All Pharmaceutical Preparations benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2834/operating-income/2023